长链非编码RNA作为胃癌诊断标志物的研究新进展
New Progress of Long Non-Coding RNA as a Diagnostic Marker for Gastric Cancer
DOI: 10.12677/ACM.2022.124527, PDF,   
作者: 李蓉蓉:延安大学附属医院,陕西 延安
关键词: 胃癌长链非编码RNA肿瘤标志物Gastric Cancer IncRNA Tumor Marker
摘要: 胃癌是常见的恶性肿瘤之一,早期诊断的效果还不理想。近几年研究表明,胃癌患者中一些长链非编码RNA表达异常,可作为胃癌诊断的标志物,治疗及预后监测的指标。本文就长链非编码RNA作为胃癌诊断标志物的研究新进展作一综述。
Abstract: Gastric cancer is one of the common malignant tumors, and the early diagnosis is not satisfactory. Research in recent years has shown that abnormal expression of some LncRNAs in patients with gastric cancer can be used as markers for diagnosis, treatment and prognostic monitoring of gastric cancer. This article reviews the recent progress of long non-coding RNA as a diagnostic marker for gastric cancer.
文章引用:李蓉蓉. 长链非编码RNA作为胃癌诊断标志物的研究新进展[J]. 临床医学进展, 2022, 12(4): 3635-3640. https://doi.org/10.12677/ACM.2022.124527

参考文献

[1] Jing, J.X., Wang, Y., Xu, X.Q., et al. (2014) Tumor Markers for Diagnosis, Monitoring of Recurrence and Prognosis in Patients with Upper Gastrointestinal Tract Cancer. Asian Pacific Journal of Cancer Prevention, 15, 10267-10272. [Google Scholar] [CrossRef
[2] Zhou, Y.C., Zhao, H.J. and Shen, L.Z. (2015) Preoperative Serum CEA and CA19-9 in Gastric Cancer—A Single Tertiary Hospital Study of 1075 Cases. Asian Pacific Journal of Cancer Prevention, 16, 2685-2691. [Google Scholar] [CrossRef
[3] Qi, P., Zhou, X.Y. and Du, X. (2016) Circulating Long Non-Coding RNAs in Cancer: Current Status and Future Perspectives. Molecular Cancer, 15, 39. [Google Scholar] [CrossRef] [PubMed]
[4] Peng, W., Wu, G., Fan, H., Wu, J. and Feng, J. (2015) Long Non-Coding RNASPRY4-IT1 Predicts Poor Patient Prognosis and Promotes Tumorigenesis in Gastric Cancer. Tumor Biology, 36, 6751-6758. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, B., Zhao, Q., Guan, L., et al. (2018) Long Non-Coding RNA NNT-AS1 Sponges miR424/E2F1 to Promote the Tumorigenesis and Cell Cycle Progression of Gastric Cancer. Journal of Cellular and Molecular Medicine, 22, 4751-4759. [Google Scholar] [CrossRef] [PubMed]
[6] Qi, H., Xiao, Z. and Wang, Y. (2019) Long Non-Coding RNA LINC00665 Gastric Cancer Tumorigenesis by Regulation miR-149-3p/RNF2 Axis. OncoTargets and Therapy, 12, 6981-6990. [Google Scholar] [CrossRef
[7] Lau, E. (2018) Non-Coding RNA: Zooming in on lncRNA Functions. Nature Reviews Genetics, 15, 574-575. [Google Scholar] [CrossRef] [PubMed]
[8] Kopp, F. and Mendell, J.T. (2018) Functional Classification and Experimental Dissection of Long Non-Coding RNAs. Cell, 172, 393-407. [Google Scholar] [CrossRef] [PubMed]
[9] Zong, Z., Li, H., Yu, Z.M., et al. (2020) Prognostic Thirteen-Long Non-Coding RNAs (IncRNAs) Could Improve the Survival Prediction of Gastric Cancer. Gastroenterologia Y Hepatologia, 43, 598-606. [Google Scholar] [CrossRef] [PubMed]
[10] Zhu, L., Jia, R., Zhang, J., Li, X., Qin, C. and Zhao, Q. (2020) Quantitative Proteomics Analysis Revealed the Potential Role of lncRNA FTX in Promoting Gastric Cancer Progression. Proteomics: Clinical Applications, 14, e1900053. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, X., Fan, Y., He, Y., et al. (2020) Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis. Journal of Oncology, 2020, Article ID: 6341093. [Google Scholar] [CrossRef] [PubMed]
[12] Zhou, J., Wu, L., Li, W., et al. (2020) Long Non-Coding RNALINC01485 Promotes Tumor Growth and Migration via Inhibiting EGFR Ubiquitination and Activating EGFR/Akt Signaling in Gastric Cancer. OncoTargets and Therapy, 13, 8413-8425. [Google Scholar] [CrossRef
[13] Zhi, X.H., Jiang, K., Ma, Y.Y. and Zhou, L.Q. (2020) OIP5AS1 Promotes the Progression of Gastric Cancer Cells via the miR-153-3p/ZBTB2 Axis. European Review for Medical and Pharmacological Sciences, 24, 2428-2441.
[14] Zheng, P., Zhang, H., Gao, H., et al. (2020) Plasma Exosomal Long Non-Coding RNAlncSLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer. OncoTargets and Therapy, 13, 4009-4018. [Google Scholar] [CrossRef
[15] Zhao, Y., Chen, X., Jiang, J., Wan, X., Wang, Y. and Xu, P. (2020) Epigallocatechin Gallate Reverses Gastric Cancer by Regulating the Long Non-Coding RNALINC00511/miR29b/KDM2A Axis. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1866, Article ID: 165856. [Google Scholar] [CrossRef] [PubMed]
[16] Zhao, S., Fan, N.F., Chen, X.H., Zhuo, C.H., Xu, C.W. and Lin, R.B. (2020) Long Non-Coding RNAPVT1-214 Enhances Gastric Cancer Progression by Upregulating TrkC Expression in Competitively Sponging Way. European Review for Medical and Pharmacological Sciences, 24, 8245.
[17] Zhang, X., Jiang, Y., Xie, Y., Leng, X., He, M. and Song, F. (2020) Inhibition of Gastric Cancer Cell Apoptosis by Long-Non-Coding RNATRPM2-AS via Mitogen-Activated Protein Kinase and Activators of Transduction-3. Journal of Gastroenterology and Hepatology, 36, 186-195. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, X., Xie, Z., Lei, X. and Gan, R. (2020) Long Non-Coding RNAGAS5 in Human Cancer. Oncology Letters, 20, 2587-2594. [Google Scholar] [CrossRef] [PubMed]
[19] Qiu, S., Chen, G., Peng, J., et al. (2020) LncRNA EGOT Decreases Breast Cancer Cell Viability and Migration via Inactivation of the Hedgehog Pathway. FEBS Open Bio, 10, 817-826. [Google Scholar] [CrossRef] [PubMed]
[20] Qian, Y., Song, W., Wu, X., et al. (2020) DLX6 Antisense RNA1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290. Digestive Diseases and Sciences, 66, 460-473. [Google Scholar] [CrossRef] [PubMed]
[21] Wu, Q., Ma, J., Wei, J., Meng, W., Wang, Y. and Shi, M. (2021) lncRNASNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/Beta-Catenin Pathway and Oncogenic Autophagy. Molecular Therapy, 29, 1258-1278. [Google Scholar] [CrossRef] [PubMed]
[22] Pan, H., Ding, Y., Jiang, Y., Wang, X., Rao, J., Zhang, X., Yu, H., Hou, Q. and Li, T. (2021) LncRNA LIFR-AS1 Promotes Proliferation and Invasion of Gastric Cancer Cell via miR-29a-3p/COL1A2 Axis. Cancer Cell International, 21, 7. [Google Scholar] [CrossRef] [PubMed]
[23] Amieva, M. and Peek Jr., R.M. (2016) Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology, 150, 64-78. [Google Scholar] [CrossRef] [PubMed]
[24] Toh, J.W. and Wilson, R.B. (2020) Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. International Journal of Molecular Sciences, 21, 6451. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, L., Shuai, T., Li, B., Zhu, L. and Li, X. (2018) Long Non-Coding RNA lnc-GNAT1-1 Inhibits Gastric Cancer Cell Proliferation and Invasion through the Wnt/β-Catenin Pathway in Helicobacter pylori Infection. Molecular Medicine Reports, 18, 4009-4015. [Google Scholar] [CrossRef] [PubMed]
[26] Rajabi, A., Bastani, S., Maydanchi, M., Tayefeh-Gholami, S., Abdolahi, S., Saber, A., et al. (2021) Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection. Journal of Gastrointestinal Cancer. [Google Scholar] [CrossRef] [PubMed]
[27] Alnajar, S.G.I., et al. (2022) Overexpression of lncRNAs H19 and UCA1 in Gastric Cancer Tissues. Gene Reports, 27. [Google Scholar] [CrossRef
[28] Ghodrati, R., Safaralizadeh, R., Dastmalchi, N., Hosseinpourfeizi, M., Asadi, M., Shirmohammadi, M., et al. (2021) Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues. Journal of Gastrointestinal Cancer. [Google Scholar] [CrossRef] [PubMed]
[29] Tayefeh-Gholami, S., Ghanbari, M., Aghazadeh, A., Rajabi, A., Saber, A. and Hussen, B.M., et al. (2021) Prognostic Value of LncRNA KRT18P55 in Patients with Intestinal Type of Gastric Cancer. Journal of Gastrointestinal Cancer. [Google Scholar] [CrossRef] [PubMed]
[30] Rajabi, A., Riahi, A., Shirabadi-Arani, H., Moaddab, Y., Haghi, M. and Safaralizadeh, R. (2020) Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection. Journal of Gastrointestinal Cancer, 53, 72-77.
[31] Zhang, J., Guo, S., Dong, Z., Zheng, Z. C., Wang, Y. and Zhao, Y. (2019) Prognostic Value of Hypoxia-Responsive Long Non-Coding RNAs in Gastric Cancer: A Meta-Analysis. International Journal of Clinical and Experimental Medicine, 12, 3558-3568.
[32] Li, H., Yu, B., Li, J., Su, L., Yan, M., Zhu, Z., et al. (2014) Overexpression of lncRNA H19 Enhances Carcinogenesis and Metastasis of Gastric Cancer. Oncotarget, 5, 2318-2329. [Google Scholar] [CrossRef] [PubMed]
[33] Han, Y., Yang, Y.-N., Yuan, H.-H., Zhang, T.-T., Sui, H., Wei, X.-L., et al. (2014) UCA1, a Long Non-Coding RNA Up-Regulated in Colorectal Cancer Influences Cell Proliferation, Apoptosis and Cell Cycle Distribution. Pathology, 46, 396-401. [Google Scholar] [CrossRef
[34] Wang, F., Zhou, J., Xie, X., Hu, J., Chen, L., Hu, Q., et al. (2015) Involvement of SRPK1 in Cisplatin Resistance Related to Long Non-Coding RNA UCA1 in Human Ovarian Cancer Cells. Neoplasma, 62, 432-438. [Google Scholar] [CrossRef] [PubMed]
[35] Jiang, H., et al. (2019) Circulating Long Non-Coding RNA PCGEM1 as a Novel Biomarker for Gastric Cancer Diagnosis. Pathology—Research and Practice, 215, Article ID: 152569. [Google Scholar] [CrossRef] [PubMed]
[36] Zhou, X., Yin, C., Dang, Y., et al. (2015) Identification of the Long Non-Coding RNAH19 in Plasma ASA Novel Biomarker for Diagnosis of Gastric Cancer. Scientific Reports, 5, Article No. 11516. [Google Scholar] [CrossRef] [PubMed]
[37] Parolia, A., Crea, F., Xue, H., et al. (2015) The Long Non-Coding RNAPCGEM1 Is Regulated by Androgen Receptor Activity in Vivo. Molecular Cancer, 14, 46. [Google Scholar] [CrossRef] [PubMed]
[38] Srikantan, V., Zou, Z., Petrovics, G., et al. (2000) PCGEM1, a Prostate-Specific Gene, Is Overexpressed in Prostate Cancer. Proceedings of the National Academy of Sciences of the United States of America, 97, 12216-12221. [Google Scholar] [CrossRef] [PubMed]
[39] Ho, T.T., Huang, J., Zhou, N., et al. (2016) Regulation of PCGEM1 by p54/NRB in Prostate Cancer. Scientific Reports, 6, Article No. 34529. [Google Scholar] [CrossRef] [PubMed]
[40] Chen, S., Wang, L.L., Sun, K.X., et al. (2018) LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression through RhoA Pathway. Cellular Physiology and Biochemistry, 47, 1578-1588. [Google Scholar] [CrossRef] [PubMed]
[41] Li, Q., Shen, F. and Zhao, L. (2018) The Relationship between lncRNA PCGEM1 and STAT3 during the Occurrence and Development of Endometrial Carcinoma. Biomedicine & Pharmacotherapy, 107, 918-928. [Google Scholar] [CrossRef] [PubMed]
[42] Park, J.Y., Lee, J.E., Park, J.B., et al. (2014) Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Research and Treatment, 2, 1-6. [Google Scholar] [CrossRef] [PubMed]
[43] Meng, S., et al. (2021) Expression of Long Non-Coding RNA LINC01279 in Gastric Adenocarcinoma and Its Clinical Significance. Asian Journal of Surgery. [Google Scholar] [CrossRef] [PubMed]
[44] Liu, W., et al. (2020) Circulating Long Non-Coding RNA FEZF1-AS1 and AFAP1-AS1 Serve as Potential Diagnostic Biomarkers for Gastric Cancer. Pathology—Research and Practice, 216, Article ID: 152757. [Google Scholar] [CrossRef] [PubMed]
[45] Wu, X., Zhang, P., Zhu, H., et al. (2017) Long Non-Coding RNAFEZF1-AS1 Indicates a Poor Prognosis of Gastric Cancer and Promotes Tumorigenesis via Activation of Wnt Signaling Pathway. Biomedicine & Pharmacotherapy, 96, 1103-1108. [Google Scholar] [CrossRef] [PubMed]
[46] Guo, J.Q., Li, S.J. and Guo, G.X. (2017) Long Non-Coding RNAAFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Digestive Diseases and Sciences, 62, 2004-2010. [Google Scholar] [CrossRef] [PubMed]
[47] Jing, R., et al. (2020) Determination of Serum RP11-731F5.2 as a Noninvasive Biomarker for Gastric Cancer Diagnosis and Prognosis. Pathology—Research and Practice, 216, Article ID: 153261. [Google Scholar] [CrossRef] [PubMed]